2016年6月2日

2016年6月1日Medella健康,分享公司的創始團隊包括泰爾研究員和賽車穀歌和諾華發展glucose-sensing隱形眼鏡,已經籌集了140萬美元資金。沒有太多的已知Medella的鏡頭。該公司表示,它將把一個小傳感器芯片,和micro-antenna葡萄糖讀數傳送給移動設備,並在接近實時用戶跟蹤他們的葡萄糖。他們最大的創新是一個傳感器聲稱,將持續一個月,創始人兼首席執行官哈裏·甘地說給他們勝過生命科學(原穀歌),實在為諾華製藥正在開發一個類似的技術。“至於實在和團隊所做的工作,他們之前在微電子技術和領先的傳感技術,“甘地在一封電子郵件中告訴MobiHealthNews。“我們的傳感器能夠持續30天(而不是幾天),顯著延長隱形眼鏡的生命周期,從而使校準更簡單得多用戶和降低成本的血糖監測。“甘地說,該公司將使用種子資金規模的技術和尋找合作夥伴生產和銷售該產品的其他方麵,包括micro-fabrication公司、隱形眼鏡製造商和衛生保健提供者。“我們有一個令人興奮的未來一年的我們,”他在一份聲明中說。“我們已經召集了一些最聰明的人們工作的問題是根深蒂固的在我們的醫療保健係統。從未有一個更好的時間來做這個,我們的醫療保健係統中斷的時機已經成熟,行業領袖和關鍵意見領袖倡導從被動轉向醫療保健預防模式的典範。“從理論上講,隱形眼鏡可以檢測一個人的血糖水平基於他們的眼淚。 But when MobiHealthNews interviewed several industry experts in 2014 -- after Google announced its project -- they all expressed various levels of skepticism that reliable glucose monitoring via a contact lens could be done. But now the question seems to be not "Can it be done? " but "Who will do it first? " Even with Peter Thiel's vote of confidence, Medella seems like something of an underdog. The company has been working on this for three years, and Gandhi is still confident in their efforts. "We’re extremely proud of how we’ve brought the team together and all the work we’ve done since we first started in early 2013," he said in a statement. "The months ahead are going to be an extremely exciting time for us, as we will be perfecting the technology we’ve built and working with the regulatory bodies to get approval.” Tags: